| Financial Year |
March 31 2023 |
| Monetary Funds |
1,820,572,128.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
314,568,097.52 |
| Accounts Receivable |
2,379,318,003.32 |
| Advances to Suppliers |
160,689,534.93 |
| Other Receivables |
13,344,317.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,237,248,865.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,797,493.68 |
| Total Current Assets |
5,936,538,441.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
100,725,764.01 |
| Investment Properties |
261,049,473.00 |
| Fixed Assetes |
1,064,070,013.24 |
| Under-construction Projects |
167,663,006.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
468,280,179.35 |
| R&D expenses |
23,162,694.26 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
26,396,202.93 |
| Deferred Income Tax Assets |
14,278,904.36 |
| Other Non-Current Assets |
80,688,451.36 |
| Sub-Total of Non-Current Assets |
2,280,560,934.95 |
| Total Assets |
8,217,099,376.07 |
| Short-Term Loans |
3,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
61,397,525.57 |
| Accounts Payable |
1,310,605,746.59 |
| Accounts Received In Advance |
46,757,570.20 |
| Employee Compensation Payable |
21,458,588.44 |
| Taxes Payable |
49,966,636.66 |
| Interest Payable |
-- |
| Dividend Payable |
1,222,948.11 |
| Other payables |
68,588,799.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,952,554.74 |
| Other Current Liabilities |
64,114,978.11 |
| Sub-Total of Current Liabilities |
1,973,313,100.51 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-8,620,988.21 |
| Special Payable |
-- |
| Estimatied Liabilities |
88,748.80 |
| Deferred Income Tax Liabilities |
8,502,511.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
272,910,767.54 |
| Total Liabilities |
2,246,223,868.05 |
| Paid-In Capital(Or Share Stock) |
1,680,185,294.11 |
| Capital Surplus |
1,464,575,104.26 |
| Surplus Reserve |
1,068,270,384.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,547,863,555.62 |
| Minority Stockholder's Interest |
200,558,722.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,770,316,785.40 |
| Owner's Equity（Stockholder's Equity） |
5,970,875,508.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,217,099,376.07 |
